Medtronic (NYSE:MDT) today announced a voluntary recall warning of battery issues with its MiniMed 600 and 700 series insulin pumps. FDA deemed the recall Class I, the most serious kind. The medtech giant issued a field action starting on July 31, notifying customers to follow built-in alerts for battery status. Customers should contact Medtronic if […]
Medtronic
The 9 largest diabetes technology companies in the world
Diabetes technology comes in all shapes and sizes: insulin delivery systems, continuous glucose monitors and more. The companies that develop these technologies come in all shapes and sizes, too. Some focus entirely (or almost entirely) on solutions for people with diabetes. Others are much larger medtech firms that still have sizable business units that focus […]
Medtronic wants to be No. 1 in automated insulin delivery as Q1 results highlight Diabetes growth
Medtronic (NYSE:MDT) reported more growth in its Diabetes unit as the company’s recent moves signal its intent in the competitive insulin pump market. The company’s first-quarter (fiscal 2025) results included $647 million in revenue from the Diabetes unit. That marked 11% year-over-year growth from the same three-month period a year ago. U.S. revenues grew in […]
Medtronic wins FDA nod for next-gen Simplera CGM
Medtronic (NYSE:MDT) announced today that it received FDA approval for its Simplera continuous glucose monitor (CGM). It marks another boost for Medtronic’s CGM portfolio, which will also include an integrated CGM offering through a collaboration with Abbott announced today. Simplera, the company’s first disposable, all-in-one CGM, comes in at half the size of previous Medtronic […]
Abbott, Medtronic partner to connect CGM, insulin delivery systems
Abbott (NYSE:ABT) and Medtronic (NYSE:MDT) today announced a global partnership pairing Abbott CGMs with Medtronic insulin delivery systems. The partnership aims to collaborate on a system based on Abbott’s FreeStyle Libre continuous glucose monitors (CGMs) with Medtronic’s automated insulin delivery technology (the latest generation being the MiniMed 780G) and smart insulin pen systems, such as […]
The biggest stories from the American Diabetes Association (ADA) 2024 Scientific Sessions
The American Diabetes Association took to Orlando, Florida, the past few days for its 84th Scientific Sessions as optimism grows over diabetes tech. Topics covered included expanding technologies to the type 2 diabetes population (90% of people with diabetes), GLP-1 drugs, automation, broadening user bases and more. The usual big-hitters stepped up to the plate […]
How Medtronic developed its latest automated insulin delivery systems
In 2011, Lou Lintereur says Medtronic began “getting more serious” about commercializing automated insulin delivery technology. This process started out simply and built up to the closed-loop technologies we know today, like the MiniMed 780G. However, in order to get there, the company needed engineers with a background in control systems. Lintereur, the company’s chief engineer […]
Medtronic data shows reduced diabetes burdens with MiniMed 780G
Medtronic (NYSE:MDT) today announced new study results highlighting the benefits of its MiniMed 780G automated insulin delivery system. New data shows how the system addresses hyperglycemia and nighttime burden to tackle the unique burdens and challenges of diabetes. Those include managing highs and meal-time management or carb-counting. The company said its latest data also mirrors […]
Medtronic Diabetes has a new medical affairs director
Medtronic (NYSE:MDT) announced today that Dr. Goran Petrovski joined its Diabetes operating unit as medical affairs director. His role includes shaping the clinical evidence strategy and product design for Medtronic’s diabetes technology. The company also expects him to strengthen its presence in Central Europe, the Middle East and Africa. Petrovski brings more than 20 years […]
Medtronic MiniMed 780G recognized as a ‘World-Changing Idea’
Fast Company has named the Medtronic (NYSE:MDT) MiniMed 780G automated insulin delivery system among the “Best World-Changing Ideas” of 2024. The next-generation MiniMed 780G system won FDA approval just over a year ago. It uses the latest Guardian 4 technology and requires no fingersticks while in “SmartGuard” mode. The system provides meal detection technology providing […]
